Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Immediate versus deferred androgen-deprivation therapy for prostate cancer: the jury is still out

Nature Clinical Practice Urology volume 3, pages 474–475 (2006)Cite this article

boxed-textStuder UE et al. (2006) Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891. J Clin Oncol 24: 1868–1876

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. The Medical Research Council Prostate Cancer Working Party Investigators Group (1997) Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial. Br J Urol 79: 235–246

  2. Abrahamsson PA et al. (2005) Risks and benefits of hormonal manipulation as monotherapy or adjuvant treatment in localised prostate cancer. Eur Urol 48: 900–905

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Sandra Ford, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Senior Faculty in Urology at the University Clinics of Brussels in Brussels, Belgium

    Alexandre R Zlotta & Claude Schulman

  2. Chief of the Department of Urology at Erasme Hospital, University Clinics of Brussels, and a Professor of Urology at the University of Brussels,

    Alexandre R Zlotta & Claude Schulman

Authors
  1. Alexandre R Zlotta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claude Schulman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexandre R Zlotta.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zlotta, A., Schulman, C. Immediate versus deferred androgen-deprivation therapy for prostate cancer: the jury is still out. Nat Rev Urol 3, 474–475 (2006). https://doi.org/10.1038/ncpuro0579

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0579

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing